Palliative Care Research
Online ISSN : 1880-5302
ISSN-L : 1880-5302
Case Reports
A case of nephrotic syndrome (NS) with advanced uterine cancer, in which the patient's QOL was greatly improved by treatment of NS
Koji AmanoTakashi HigashiguchiAtsushi SasanabeHiroshi OharaMiyo MuraiAkihiro ItoTetsuo SadamotoAkihiko FutamuraKenzo Shibata
Author information
JOURNAL FREE ACCESS

2011 Volume 6 Issue 1 Pages 316-323

Details
Abstract

It is not uncommon for edema in the end stage of advanced cancer to be caused by nephrotic syndrome (NS) as well as by cachexia, hypo-proteinemia due to malnutrition, or lymphedema. Such edema not only causes patients' quality of life (QOL) to be deteriorate, but may also result in earlier death in the absence of accurate diagnosis and treatment. We report a case of nephrotic syndrome with advanced uterine cancer, in which the patient's QOL was greatly improved by the accurate and timely diagnosis and treatment of NS. A 65-year old woman suffering from recurrent uterine cancer (lung and brain metastases) was admitted as an emergency due to deterioration of her general condition. Edema of both legs was severe, and laboratory findings (TP 5.0 g/dl, ALB 1.3 g/dl, T-Chol 369 mg/dl, proteinuria 3+) at the time of admission met the diagnosis criteria for NS rather than cachexia. We first administered albumin to stabilize circulation, and started treatment with prednisolone and cyclosporine, which greatly improved her general condition and edema of her legs. Subsequently, NS repeatedly improved and worsened and the tumors gradually progressed. The patient died of multiple organ failure induced by disseminated intravascular coagulation (DIC) at 81 days after admission. NS caused by malignancy is not uncommon. In general, however, such cases of NS are associated with solid tumors, such as gastrointestinal and lung cancer. NS caused by uterine cancer is very rare. We suggest that NS should be borne in mind in addition to cachexia, hypo-proteinemia or lymphedema as a possible cause of edema in the end stage of advanced cancer. Palliat Care Res 2011; 6(1): 316-323

Content from these authors
© 2011 by Japanese Society for Palliative Medicine
Previous article Next article
feedback
Top